These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 10908694)

  • 1. Transcription factor decoy for NFkappaB inhibits cytokine and adhesion molecule expressions in synovial cells derived from rheumatoid arthritis.
    Tomita T; Takano H; Tomita N; Morishita R; Kaneko M; Shi K; Takahi K; Nakase T; Kaneda Y; Yoshikawa H; Ochi T
    Rheumatology (Oxford); 2000 Jul; 39(7):749-57. PubMed ID: 10908694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of TNF-alpha, induced cytokine and adhesion molecule. Expression in glomerular cells in vitro and in vivo by transcription factor decoy for NFkappaB.
    Tomita N; Morishita R; Tomita S; Kaneda Y; Higaki J; Ogihara T; Horiuchi M
    Exp Nephrol; 2001; 9(3):181-90. PubMed ID: 11340302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E2F decoy oligodeoxynucleotide ameliorates cartilage invasion by infiltrating synovium derived from rheumatoid arthritis.
    Tomita T; Kunugiza Y; Tomita N; Takano H; Morishita R; Kaneda Y; Yoshikawa H
    Int J Mol Med; 2006 Aug; 18(2):257-65. PubMed ID: 16820932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor kappaB decoy oligodeoxynucleotides as a gene therapy.
    Tomita T; Takeuchi E; Tomita N; Morishita R; Kaneko M; Yamamoto K; Nakase T; Seki H; Kato K; Kaneda Y; Ochi T
    Arthritis Rheum; 1999 Dec; 42(12):2532-42. PubMed ID: 10615998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcription factor decoy for NFkappaB inhibits TNF-alpha-induced cytokine and adhesion molecule expression in vivo.
    Tomita N; Morishita R; Tomita S; Gibbons GH; Zhang L; Horiuchi M; Kaneda Y; Higaki J; Ogihara T; Dzau VJ
    Gene Ther; 2000 Aug; 7(15):1326-32. PubMed ID: 10918504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion.
    Woolley DE; Tetlow LC
    Arthritis Res; 2000; 2(1):65-74. PubMed ID: 11219391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intercellular adhesion molecule-1 mediates the inhibitory effects of hyaluronan on interleukin-1beta-induced matrix metalloproteinase production in rheumatoid synovial fibroblasts via down-regulation of NF-kappaB and p38.
    Hiramitsu T; Yasuda T; Ito H; Shimizu M; Julovi SM; Kakinuma T; Akiyoshi M; Yoshida M; Nakamura T
    Rheumatology (Oxford); 2006 Jul; 45(7):824-32. PubMed ID: 16449361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneous requirement of IkappaB kinase 2 for inflammatory cytokine and matrix metalloproteinase production in rheumatoid arthritis: implications for therapy.
    Andreakos E; Smith C; Kiriakidis S; Monaco C; de Martin R; Brennan FM; Paleolog E; Feldmann M; Foxwell BM
    Arthritis Rheum; 2003 Jul; 48(7):1901-12. PubMed ID: 12847684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of inflammatory cytokines and prostaglandin E2 by IL-13 gene therapy in rheumatoid arthritis synovium.
    Woods JM; Katschke KJ; Tokuhira M; Kurata H; Arai KI; Campbell PL; Koch AE
    J Immunol; 2000 Sep; 165(5):2755-63. PubMed ID: 10946307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncostatin M induces angiogenesis and cartilage degradation in rheumatoid arthritis synovial tissue and human cartilage cocultures.
    Fearon U; Mullan R; Markham T; Connolly M; Sullivan S; Poole AR; FitzGerald O; Bresnihan B; Veale DJ
    Arthritis Rheum; 2006 Oct; 54(10):3152-62. PubMed ID: 17009243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An investigation of cell proliferation and soluble mediators induced by interleukin 1beta in human synovial fibroblasts: comparative response in osteoarthritis and rheumatoid arthritis.
    Inoue H; Takamori M; Nagata N; Nishikawa T; Oda H; Yamamoto S; Koshihara Y
    Inflamm Res; 2001 Feb; 50(2):65-72. PubMed ID: 11289656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of rheumatoid arthritis is associated with a reduction in synovial membrane cytokines and cell adhesion molecule expression.
    Smith MD; Slavotinek J; Au V; Weedon H; Parker A; Coleman M; Roberts-Thomson PJ; Ahern MJ
    Rheumatology (Oxford); 2001 Sep; 40(9):965-77. PubMed ID: 11561106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcription factor decoy for nuclear factor-kappaB inhibits tumor necrosis factor-alpha-induced expression of interleukin-6 and intracellular adhesion molecule-1 in endothelial cells.
    Tomita N; Morishita R; Tomita S; Yamamoto K; Aoki M; Matsushita H; Hayashi S; Higaki J; Ogihara T
    J Hypertens; 1998 Jul; 16(7):993-1000. PubMed ID: 9794740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of interleukin-18 expression with enhanced levels of both interleukin-1beta and tumor necrosis factor alpha in knee synovial tissue of patients with rheumatoid arthritis.
    Joosten LA; Radstake TR; Lubberts E; van den Bersselaar LA; van Riel PL; van Lent PL; Barrera P; van den Berg WB
    Arthritis Rheum; 2003 Feb; 48(2):339-47. PubMed ID: 12571842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous injection of oligodeoxynucleotides to the NF-kappaB binding site inhibits hepatic metastasis of M5076 reticulosarcoma in mice.
    Kawamura I; Morishita R; Tsujimoto S; Manda T; Tomoi M; Tomita N; Goto T; Ogihara T; Kaneda Y
    Gene Ther; 2001 Jun; 8(12):905-12. PubMed ID: 11426330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of NFkappaB activation using cis-element 'decoy' of NFkappaB binding site reduces neointimal formation in porcine balloon-injured coronary artery model.
    Yamasaki K; Asai T; Shimizu M; Aoki M; Hashiya N; Sakonjo H; Makino H; Kaneda Y; Ogihara T; Morishita R
    Gene Ther; 2003 Feb; 10(4):356-64. PubMed ID: 12595894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of cytokines and ICAM-1 by proinflammatory cytokines in primary rheumatoid synovial fibroblasts and inhibition by N-acetyl-L-cysteine and aspirin.
    Sakurada S; Kato T; Okamoto T
    Int Immunol; 1996 Oct; 8(10):1483-93. PubMed ID: 8921427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of nuclear factor-kappaB decoy transfection on nuclear factor-kappaB activity and vascular endothelial growth factor/urokinase-type plasminogen activator/intercellular cell adhesion molecule-1 level of SKOV3 cells].
    Lu JP; Sun H; Cao CC; Ou ZL
    Zhonghua Fu Chan Ke Za Zhi; 2004 Aug; 39(8):533-7. PubMed ID: 15363352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of Fcgamma receptors II and III on macrophages of rheumatoid arthritis patients results in higher production of tumor necrosis factor alpha and matrix metalloproteinase.
    Blom AB; Radstake TR; Holthuysen AE; Slöetjes AW; Pesman GJ; Sweep FG; van de Loo FA; Joosten LA; Barrera P; van Lent PL; van den Berg WB
    Arthritis Rheum; 2003 Apr; 48(4):1002-14. PubMed ID: 12687542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rheumatoid synovial fibroblasts are stimulated by the cellular adhesion to T cells through lymphocyte function associated antigen-1/intercellular adhesion molecule-1.
    Nakatsuka K; Tanaka Y; Hubscher S; Abe M; Wake A; Saito K; Morimoto I; Eto S
    J Rheumatol; 1997 Mar; 24(3):458-64. PubMed ID: 9058649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.